dc.contributor.author
Bousquet, Jean
dc.contributor.author
Haahtela, Tari
dc.contributor.author
Blain, Hubert
dc.contributor.author
Czarlewski, Wienczyslawa
dc.contributor.author
Zuberbier, Torsten
dc.contributor.author
Bedbrook, Anna
dc.contributor.author
Cruz, Alvaro A.
dc.contributor.author
Fonseca, Joao A.
dc.contributor.author
Klimek, Ludger
dc.contributor.author
Kuna, Piotr
dc.contributor.author
Samolinski, Boleslaw
dc.contributor.author
Valiulis, Arunas
dc.contributor.author
Lemaire, Antoine
dc.contributor.author
Anto, Josep M.
dc.date.accessioned
2024-12-03T14:38:07Z
dc.date.available
2024-12-03T14:38:07Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/45831
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-45544
dc.description.abstract
Vaccination is a highly effective preventive measure against COVID-19. However, complementary treatments are needed to better control the disease. Fermented vegetables and spices, agonists of the antioxidant transcription factor nuclear factor (erythroid-derived 2)-like 2 (Nrf2) and TRPA1/V1 channels (Transient Receptor Potential Ankyrin 1 and Vanillin 1), may help in the control of COVID-19. Some preliminary clinical trials suggest that curcumin (spice) can prevent some of the COVID-19 symptoms. Before any conclusion can be drawn and these treatments recommended for COVID-19, the data warrant confirmation. In particular, the benefits of the foods need to be assessed in more patients, through research studies and large trials employing a double-blind, placebo-controlled design.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Available and affordable complementary treatments for COVID‐19: From hypothesis to pilot studies and the need for implementation
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
e12127
dcterms.bibliographicCitation.doi
10.1002/clt2.12127
dcterms.bibliographicCitation.journaltitle
Clinical and Translational Allergy
dcterms.bibliographicCitation.number
3
dcterms.bibliographicCitation.originalpublishername
Wiley
dcterms.bibliographicCitation.volume
12
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
DEAL Wiley
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
35344297
dcterms.isPartOf.eissn
2045-7022